Neurosciences Division, Center for Applied Medical Research (CIMA and CIBERNED), University of Navarra Medical College, Pamplona, Navarra, Spain.
J Psychopharmacol. 2011 Jan;25(1):97-104. doi: 10.1177/0269881110367732. Epub 2010 May 20.
The putative presence of the cannabinoid receptor type 2 (CB(2)-R) in the central nervous system is still a matter of debate. Although first described in peripheral and immune tissues, evidence suggesting the existence of CB(2)-Rs in glial cells and even neurons has been made available more recently. By taking advantage of newly designed CB(2)-R mRNA riboprobes, we have demonstrated by in situ hybridization and PCR the existence of CB2-R transcripts in a variety of brain areas of the primate Macaca fascicularis, including the cerebral cortex and the hippocampus, as well as in the external and internal divisions of the globus pallidus, both pallidal segments showing the highest abundance of CB(2)-R transcripts. In this regard, the presence of the messenger coding CB(2)-Rs within the pallidal complex highlights their consideration as potential targets for the treatment of movement disorders of basal ganglia origin.
大麻素受体 2 型(CB2-R)在中枢神经系统中的存在仍然存在争议。尽管最初在周围和免疫组织中描述,但最近提供的证据表明,神经胶质细胞甚至神经元中存在 CB2-R。通过利用新设计的 CB2-R mRNA 探针,我们通过原位杂交和 PCR 证明了 CB2-R 转录本存在于灵长类动物猕猴的多种大脑区域中,包括大脑皮层和海马体,以及苍白球的外部和内部区域,这两个苍白球区域显示出 CB2-R 转录本的最高丰度。在这方面,信使编码 CB2-Rs 存在于苍白球复合体中,突出了它们作为治疗基底神经节起源的运动障碍的潜在靶点的考虑。